D. Wendling

Publication List Details

Period

1996 - 2006

Number

35

Co-Authors

ASAS/EULAR recommendations for the management of ankylosing spondylitis. (2006)

Zochling, J, Burgos Vargas, R, Collantes, E, Davis, J C, Dijkmans, B, ...

OBJECTIVE: To develop evidence based recommendations for the management of ankylosing spondylitis (AS) as a combined effort of the 'ASsessment in AS' international working group and the European...

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up (2006)

Gossec, L., Le Henanff, A., Breban, M., Vignon, E., Claudepierre, P., Devauchelle, V., ...

Objective. To evaluate the continuation and safety of treatment with infliximab in ankylosing spondylitis (AS) over a 2-yr period. Methods. This study was an open, observational, 2-yr extension study...

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up (2006)

Gossec, L., Henanff, A. Le, Breban, M., Vignon, E., Claudepierre, P., Devauchelle, V., ...

Objective. To evaluate the continuation and safety of treatment with infliximab in ankylosing spondylitis (AS) over a 2-yr period. Methods. This study was an open, observational, 2-yr extension study...

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up (2006)

Gossec, L., Henanff, A. Le, Breban, M., Vignon, E., Claudepierre, P., Devauchelle, V., ...

Objective. To evaluate the continuation and safety of treatment with infliximab in ankylosing spondylitis (AS) over a 2-yr period. Methods. This study was an open, observational, 2-yr extension study...

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis (2005)

Toussirot, É., Nguyen, N. U., Dumoulin, G., Aubin, F., Wendling, D.

Objectives. Hormonal factors playing a role in bone mass and body composition have been rarely assessed in rheumatoid arthritis (RA). In this study, we aimed to evaluate the growth hormone...

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis (2004)

Toussirot, É., Nguyen, N. U., Dumoulin, G., Aubin, F., Wendling, D.

Objectives. Hormonal factors playing a role in bone mass and body composition have been rarely assessed in rheumatoid arthritis (RA). In this study, we aimed to evaluate the growth hormone...

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis (2004)

Toussirot, É., Nguyen, N. U., Dumoulin, G., Aubin, F., Wendling, D.

Objectives. Hormonal factors playing a role in bone mass and body composition have been rarely assessed in rheumatoid arthritis (RA). In this study, we aimed to evaluate the growth hormone...

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study (2002)

Breban, M., Vignon, E., Claudepierre, P., Devauchelle, V., Wendling, D., Lespessailles, E., ...

Objective. To evaluate the efficacy and safety of a loading regimen of the anti‐tumour necrosis factor α (TNF‐α) antibody infliximab in predominantly axial severe ankylosing...

Bone density, ultrasound measurements and body composition in early ankylosing spondylitis (2001)

Toussirot, E., Michel, F., Wendling, D.

Objectives. In this cross‐sectional study, we evaluated bone density using both dual‐energy X‐ray absorptiometry (DEXA) and quantitative ultrasound (QUS)...

Rheumatic disorders developed after hepatitis B vaccination (1999)

Maillefert, J. F., Sibilia, J., Toussirot, E., Vignon, E., Eschard, J. P., Lorcerie, B., ...

Objective. To obtain an overview of rheumatic disorders occurring after hepatitis B vaccination. Methods. A questionnaire was sent to rheumatology departments in nine French hospitals. Criteria for...

Bronchoalveolar lavage in ankylosing spondylitis.

Wendling, D, Dalphin, J C, Toson, B, Depierre, A, Guidet, M

Bronchoalveolar lavage and bronchial biopsies were performed in 15 patients with ankylosing spondylitis (AS) and 17 control subjects. There was no difference in total cell count, number of...

Adult onset Still's disease and related renal amyloidosis.

Wendling, D, Humbert, P G, Billerey, C, Fest, T, Dupond, J L

A 57 year old woman presented with clinical and biological features of adult onset Still's disease. A kidney biopsy was performed at the onset of the condition and was found to be normal. Four years...

Spondylodiscitis in SAPHO syndrome. A series of eight cases

Toussirot, E, Dupond, J, Wendling, D

OBJECTIVE—To determine the frequency, clinical features, and radiological and bone scintigraphic changes of spondylodiscitis in patients with SAPHO (synov-itis, acne, pustulosis, hyperostosis, and...

Abnormal autonomic cardiovascular control in ankylosing spondylitis

Toussirot, E., Bahjaoui-Bouhaddi, M., Poncet, J., Cappelle, S., Henriet, M., Wendling, D., ...

OBJECTIVE—This study was aimed at assessing the contribution of the autonomic nervous system to adjustments of cardiovascular function in patients with ankylosing spondylitis (AS).
METHODS—In...

Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis

Toussirot, E., Wendling, D., Tiberghien, P., Luka, J., Roudier, J.

OBJECTIVES—Rheumatoid arthritis (RA) is a chronic joint disease associated with certain HLA-DR alleles expressing the QK/RRAA motif or shared epitope. The Epstein-Barr virus (EBV) has been...

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies

DROUART, M, SAAS, P, BILLOT, M, CEDOZ, J-P, TIBERGHIEN, P, WENDLING, D, ...

Angiogenesis is involved in chronic inflammatory joint diseases such as rheumatoid arthritis (RA). Vascular endothelial growth factor (VEGF) plays a crucial role in angiogenesis. The...

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

Gottenberg, J, Guillevin, L, Lambotte, O, Combe, B, Allanore, Y, Cantagrel, A, ...

Objective: To assess the tolerance and efficacy of rituximab in patients with various autoimmune diseases seen in daily rheumatological practice.